SCHEMBL2859012

SCHEMBL2859012

CCOC(=O)CC(O)c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
KEAP1 Q14145 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.41
RAB9A P51151 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867866 1.00 ALDH1A1 (0.43) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2859011 1.00 ALDH1A1 (0.43) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2871203 0.88 CES2 (0.40) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2871207 0.88 CES2 (0.40) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2872072 0.88 CES2 (0.40) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2867482 0.85 L3MBTL1 (0.45) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2867478 0.85 L3MBTL1 (0.45) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2869745 0.85 L3MBTL1 (0.45) ALDH1A1CES2CES1KEAP1TSHR
SCHEMBL2515076 0.85 NPC1 (0.42) ALDH1A1CES2CES1KEAP1RAB9A
SCHEMBL2865878 0.85 ALDH1A1 (0.41) ALDH1A1CES2CES1KEAP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117089533-A Recombinant carbonyl reductase, mutant, coding gene and application thereof 浙江工业大学 2023-11-21 CN claimed
US-8293899-B2 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates LANXESS DEUTSCHLAND GMBH (DE) 2012-10-23 US claimed
CN-117089533-A Recombinant carbonyl reductase, mutant, coding gene and application thereof 浙江工业大学 2023-11-21 CN disclosed
CN-110129307-B Immobilized ketoreductase mutant and application thereof in preparation of duloxetine chiral alcohol intermediate and analogue thereof 安徽趣酶生物科技有限公司 2023-09-05 CN disclosed
US-20100069683-A1 Organic metal compound and process for preparing optically-active alcohols using the same KANTO KAGAKU KABUSHIKI KAISHA (JP) 2010-03-18 US disclosed
US-7659409-B2 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2010-02-09 US disclosed
US-20090062573-A1 Organic metal compound and process for preparing optically-active alcohols using the same KANTO KAGAKU KABUSHIKI KAISHA (JP) 2009-03-05 US disclosed
US-20060264641-A1 Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives BERENDES FRANK 2006-11-23 US disclosed
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2005-05-19 US disclosed
EP-1486493-A1 3-HYDROXY-3-(2-THIENYL)PROPIONAMIDE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING 3-AMINO-1-(2-THIENYL)-1-PROPANOL COMPOUND THEREFROM Mitsubishi Chemical Corporation (JP) 2004-12-15 EP disclosed
JP-2004267130-A NEW CARBONYL REDUCTASE AND DNA ENCODING THE SAME REDUCTASE AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL BY USING THOSE MITSUBISHI CHEMICALS CORP 2004-09-30 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062573-A1 Organic metal compound and process for preparing optically-active alcohols using the same ADH1C, ADH1A, ADH5 ALDH1A1 26/4885CES2 1519/4885CES1 706/4885
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same APEH, AADAC, KMO ALDH1A1 174/4885CES2 719/4885CES1 126/4885
US-20060264641-A1 Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives HPD, HAAO, GRHPR ALDH1A1 195/4885CES2 888/4885CES1 188/4885
US-20100069683-A1 Organic metal compound and process for preparing optically-active alcohols using the same ADH1C, ADH1A, ADH5 ALDH1A1 26/4885CES2 1519/4885CES1 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.